Uncategorized

Here are five companies and practices focused on ENT and five leading ENT device vendors:

The urology market is poised for growth, according to a recent collection of statistics from investment bank Global Healthcare Advisors.

  Menlo Park, Calif.-based Intersect ENT shared its third-quarter financial results in a Nov. 2 press release. Here are five takeaways:

The COVID-19 pandemic has "changed everything in the ambulatory surgery space, including strategic planning and supply chain," according to Helene Levenson, BSN, RN, senior consultant of clinical operations for Cardinal Health.

As of March, California had more professionally active surgery specialists than any other state and Washington, D.C., according to Kaiser Family Foundation data.

Urosurgical Center of Richmond (Va.) is using a LightStrike Germ-Zapping Robot to bolster its infection prevention efforts, according to an October announcement.

  An otolaryngologist with Tarrytown, N.Y.-based ENT and Allergy Associates relocated from the practice's Manhattan office to one in New Jersey, according to a Nov. 4 press release.

Atlanta-based Southern Ear, Nose, Throat & Allergy Partners has a strategic interest in affiliating with practices that own ASCs, two executives of the private-equity backed group said in a November interview.

Gender disparities remain in 2020, with some specialties more unequal than others, according to Doximity's "2020 Physician Compensation Report" released Oct. 29.

  Barbara Auguste will join Tarrytown, N.Y.-based ENT and Allergy Associates Nov. 9 as its new director of regulatory affairs, the practice announced in a Nov. 3 press release.